Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bech

Showing results (201-210 of 291) with videos related to

Pageof 30
Sort By:
Pharmacopsychiatry|March 4, 2008
Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trialL G Bretlau, M Lunde, L Lindberg, et al.
Journal of Affective Disorders|March 3, 2012
The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramineP Bech, K B Stage, J K Larsen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2016
Thiazide Responsiveness Testing in Patients With Renal Magnesium Wasting and Correlation With Genetic Analysis: A Diagnostic Test StudyAnneke P Bech, Jack F Wetzels, Ernie M H F Bongers, et al.
Science (New York, N.Y.)|March 2, 1973
Cannabis and alcohol: effects on stimulated car drivingO J Rafaelsen, P Bech, J Christiansen, et al.
Acta Psychiatrica Scandinavica|March 1, 1975
Quantitative rating of depressive statesP Bech, L F Gram, E Dein, et al.
Journal of Epidemiology and Community Health|October 12, 2000
Fatigue in the Danish general population. Influence of sociodemographic factors and diseaseT Watt, M Groenvold, J B Bjorner, et al.
Acta Psychiatrica Scandinavica|October 1, 1996
Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapyL Lauritzen, K Odgaard, L Clemmesen, et al.
Psychopharmacology|February 1, 1994
Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical studyL Lauritzen, B B Bendsen, T Vilmar, et al.
Psychiatry Research|November 1, 1988
Platelet 3H-imipramine binding in psychogenic pain patientsE T Mellerup, P Bech, H J Hansen, et al.
Pharmacopsychiatry|September 8, 2010
Identifying patients with therapy-resistant depression by using factor analysisK Andreasson, V Liest, M Lunde, et al.
Pageof 30

Showing results (201-210 of 291) with videos related to

Sort By:
Pageof 30
Pharmacopsychiatry|March 4, 2008
Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trialL G Bretlau, M Lunde, L Lindberg, et al.
Journal of Affective Disorders|March 3, 2012
The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramineP Bech, K B Stage, J K Larsen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2016
Thiazide Responsiveness Testing in Patients With Renal Magnesium Wasting and Correlation With Genetic Analysis: A Diagnostic Test StudyAnneke P Bech, Jack F Wetzels, Ernie M H F Bongers, et al.
Science (New York, N.Y.)|March 2, 1973
Cannabis and alcohol: effects on stimulated car drivingO J Rafaelsen, P Bech, J Christiansen, et al.
Acta Psychiatrica Scandinavica|March 1, 1975
Quantitative rating of depressive statesP Bech, L F Gram, E Dein, et al.
Journal of Epidemiology and Community Health|October 12, 2000
Fatigue in the Danish general population. Influence of sociodemographic factors and diseaseT Watt, M Groenvold, J B Bjorner, et al.
Acta Psychiatrica Scandinavica|October 1, 1996
Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapyL Lauritzen, K Odgaard, L Clemmesen, et al.
Psychopharmacology|February 1, 1994
Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical studyL Lauritzen, B B Bendsen, T Vilmar, et al.
Psychiatry Research|November 1, 1988
Platelet 3H-imipramine binding in psychogenic pain patientsE T Mellerup, P Bech, H J Hansen, et al.
Pharmacopsychiatry|September 8, 2010
Identifying patients with therapy-resistant depression by using factor analysisK Andreasson, V Liest, M Lunde, et al.
Pageof 30